Advertisement
Screener

PURPLE BIOTECH LTD. (PPBT) Form 6-K: Report of foreign private issuer, 2023

PURPLE BIOTECH LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-20: Form 6-K; Period of report 2023-12-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190401-6k_purplebio.htm.
  • 2023-12-14: Form 6-K; Period of report 2023-12-14; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190013-6k_purplebiote.htm.
  • 2023-11-21: Form 6-K; Period of report 2023-11-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea188843-6k_purplebiotech.htm.
  • 2023-11-21: Form 6-K; Period of report 2023-11-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea188818-6k_purplebiotech.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-206-K2023-12-20REPORT OF FOREIGN PRIVATE ISSUERea190401-6k_purplebio.htm
2023-12-146-K2023-12-14REPORT OF FOREIGN PRIVATE ISSUERea190013-6k_purplebiote.htm
2023-11-216-K2023-11-21REPORT OF FOREIGN PRIVATE ISSUERea188843-6k_purplebiotech.htm
2023-11-216-K2023-11-21REPORT OF FOREIGN PRIVATE ISSUERea188818-6k_purplebiotech.htm
2023-11-026-K2023-11-02REPORT OF FOREIGN PRIVATE ISSUERea187646-6k_purplebiotech.htm
2023-10-196-K2023-10-19REPORT OF FOREIGN PRIVATE ISSUERea187001-6k_purplebio.htm
2023-10-196-K2023-10-19REPORT OF FOREIGN PRIVATE ISSUERea186957-6k_purplebio.htm
2023-10-176-K2023-10-17REPORT OF FOREIGN PRIVATE ISSUERea186873-6k_purple.htm
2023-10-136-K2023-10-13REPORT OF FOREIGN PRIVATE ISSUERea186712-6k_purple.htm
2023-10-066-K2023-10-06REPORT OF FOREIGN PRIVATE ISSUERea186440-6k_purple.htm
2023-10-036-K2023-10-03REPORT OF FOREIGN PRIVATE ISSUERea186226-6k_purplebio.htm
2023-09-216-K2023-09-21REPORT OF FOREIGN PRIVATE ISSUERea185549-6k_purplebio.htm
2023-09-136-K2023-09-13REPORT OF FOREIGN PRIVATE ISSUERea185148-6k_purplebio.htm
2023-08-226-K2023-08-22REPORT OF FOREIGN PRIVATE ISSUERea183968-6k_purplebio.htm
2023-07-116-K2023-07-11REPORT OF FOREIGN PRIVATE ISSUERea181619-6k_purplebiotech.htm
2023-06-206-K/A2023-06-15AMENDMENT NO. 1 TO FORM 6-Kea180578-6ka1_purplebio.htm
2023-06-156-K2023-06-15FORM 6-Kea180438-6k_purplebio.htm
2023-05-226-K2023-05-22REPORT OF FOREIGN PRIVATE ISSUERea179080-6k_purple.htm
2023-05-166-K2023-05-16REPORT OF FOREIGN PRIVATE ISSUERea178715-6k_purplebio.htm
2023-05-016-K2023-05-01REPORT OF FOREIGN PRIVATE ISSUERea177738-6k_purplebio.htm
2023-04-256-K2023-04-25REPORT OF FOREIGN PRIVATE ISSUERea177422-6k_purplebio.htm
2023-04-196-K2023-04-19REPORT OF FOREIGN PRIVATE ISSUERea177162-6k_purplebio.htm
2023-03-246-K2023-03-24REPORT OF FOREIGN PRIVATE ISSUERea175708-6k_purplebio.htm
2023-03-166-K2023-03-16REPORT OF FOREIGN PRIVATE ISSUERea175316-6k_purplebio.htm
2023-02-146-K2023-02-14REPORT OF FOREIGN PRIVATE ISSUERea173535-6k_purplebiotech.htm
2023-02-086-K2023-02-08REPORT OF FOREIGN PRIVATE ISSUERea172962-6k_purplebiotech.htm
2023-02-036-K2023-02-03REPORT OF FOREIGN PRIVATE ISSUERea172693-6k_purplebiotech.htm
2023-02-026-K2023-02-02REPORT OF FOREIGN PRIVATE ISSUERea172456-6k_purplebiotech.htm
2023-01-066-K2023-01-06REPORT OF FOREIGN PRIVATE ISSUERea171293-6k_purplebiotech.htm
2023-01-036-K2023-01-03REPORT OF FOREIGN PRIVATE ISSUERea171130-6k_purplebiotech.htm